Mingde Ma

Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer

Yonggang Zuo, Yue Li, Zhenyu Zhou et al. · Biomedicine & Pharmacotherapy · 2017 · 155 citations

Medicine, Molecular Biology, Oncology +14

<p>LINC00096 Promotes the Proliferation and Invasion by Sponging miR-383-5p and Regulating RBM3 Expression in Triple-Negative Breast Cancer</p>

Yanyan Tian, Shuguan Xia, Mingde Ma et al. · OncoTargets and Therapy · 2019 · 55 citations · Full text

Medicine, Molecular Biology, Oncology +17

Knockdown of TRIM44 inhibits the proliferation and invasion in papillary thyroid cancer cells through suppressing the Wnt/β-catenin signaling pathway

Zhenyu Zhou, Yang Liu, Mingde Ma et al. · Biomedicine & Pharmacotherapy · 2017 · 50 citations

Life Sciences, Molecular Biology, Oncology +14

The <scp>HIF</scp>‐1/<scp>SNHG1</scp>/<scp>miR</scp>‐199a‐3p/<scp>TFAM</scp> axis explains tumor angiogenesis and metastasis under hypoxic conditions in breast cancer

Yonggang Zuo, Changping Qu, Yanyan Tian et al. · BioFactors · 2021 · 38 citations

Medicine, Cancer Biology, Gene Expression +16

De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial

Xiuchun Chen, Dechuang Jiao, Jianghua Qiao et al. · The Lancet Oncology · 2024 · 33 citations

Medicine, Oncology, Pharmacology +16